China Universal Asset Management Company’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$332K Buy
12,077
+653
+6% +$17.4K 0.02% 306
2026
Q1
$307K Buy
11,424
+1,899
+20% +$56.9K 0.02% 311
2025
Q4
$293K Buy
9,525
+2,175
+30% +$67.8K 0.02% 308
2025
Q3
$225K Sell
7,350
-11,071
-60% -$270K 0.02% 325
2025
Q2
$381K Sell
18,421
-27,781
-60% -$570K 0.04% 263
2025
Q1
$905K Buy
46,202
+37,311
+420% +$783K 0.08% 200
2024
Q4
$186K Buy
8,891
+827
+10% +$18.2K 0.02% 332
2024
Q3
$197K Buy
8,064
+3,137
+64% +$83.9K 0.02% 302
2024
Q2
$124K Sell
4,927
-3,097
-39% -$87.8K 0.02% 287
2024
Q1
$240K Buy
8,024
+3,179
+66% +$93.4K 0.03% 270
2023
Q4
$154K Buy
4,845
+3,770
+351% +$118K 0.03% 233
2023
Q3
$37.9K Buy
1,075
+498
+86% +$19K 0.01% 247
2023
Q2
$21.9K Sell
577
-55
-9% -$2.19K 0.01% 258
2023
Q1
$23.9K Buy
632
+198
+46% +$7.61K 0.01% 203
2022
Q4
$18.4K Buy
434
+81
+23% +$3.34K 0.01% 180
2022
Q3
$11K Buy
+353
New +$12.4K ﹤0.01% 195

Other funds holding GMAB

China Universal Asset Management Company's GMAB Position: Q2 2026 in Review

China Universal Asset Management Company increased its Genmab (GMAB) stake by 5.7% in Q2 2026, buying an estimated $17.4K and bringing the position to 12,077 shares worth $332K. The position accounts for 0.02% of the portfolio, ranked #306.

China Universal Asset Management Company first reported a position in GMAB in Q3 2022 and has held it in 16 quarters since. The position peaked at $905K in Q1 2025. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • China Universal Asset Management Company held 12,077 shares of Genmab worth $332K as of Q2 2026.
  • China Universal Asset Management Company bought 653 Genmab shares in Q2 2026, an estimated $17.4K.
  • Genmab made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #306 holding.
  • China Universal Asset Management Company first reported a position in Genmab in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Genmab position peaked at $905K in Q1 2025.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.